首页> 美国卫生研究院文献>Briefings in Bioinformatics >Translational research platforms integrating clinical and omics data: a review of publicly available solutions
【2h】

Translational research platforms integrating clinical and omics data: a review of publicly available solutions

机译:整合临床和组学数据的转化研究平台:对公开可用解决方案的评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The rise of personalized medicine and the availability of high-throughput molecular analyses in the context of clinical care have increased the need for adequate tools for translational researchers to manage and explore these data. We reviewed the biomedical literature for translational platforms allowing the management and exploration of clinical and omics data, and identified seven platforms: BRISK, caTRIP, cBio Cancer Portal, G-DOC, iCOD, iDASH and tranSMART. We analyzed these platforms along seven major axes. (1) The community axis regrouped information regarding initiators and funders of the project, as well as availability status and references. (2) We regrouped under the information content axis the nature of the clinical and omics data handled by each system. (3) The privacy management environment axis encompassed functionalities allowing control over data privacy. (4) In the analysis support axis, we detailed the analytical and statistical tools provided by the platforms. We also explored (5) interoperability support and (6) system requirements. The final axis (7) platform support listed the availability of documentation and installation procedures. A large heterogeneity was observed in regard to the capability to manage phenotype information in addition to omics data, their security and interoperability features. The analytical and visualization features strongly depend on the considered platform. Similarly, the availability of the systems is variable. This review aims at providing the reader with the background to choose the platform best suited to their needs. To conclude, we discuss the desiderata for optimal translational research platforms, in terms of privacy, interoperability and technical features.
机译:个性化医学的兴起以及临床护理中高通量分子分析的可用性,增加了对翻译研究人员管理和探索这些数据的适当工具的需求。我们回顾了可用于管理和探索临床和组学数据的翻译平台的生物医学文献,并确定了七个平台:BRISK,caTRIP,cBio Cancer Portal,G-DOC,iCOD,iDASH和tranSMART。我们沿着七个主轴分析了这些平台。 (1)社区轴重新整理了有关项目发起人和资助人的信息,以及可用性状态和参考。 (2)我们在信息内容轴下对每个系统处理的临床和组学数据的性质进行了重组。 (3)隐私管理环境轴包含允许控制数据隐私的功能。 (4)在分析支持轴上,我们详细介绍了平台提供的分析和统计工具。我们还探讨了(5)互操作性支持和(6)系统要求。最终轴(7)平台支持列出了文档和安装过程的可用性。除了组学数据,表型信息的安全性和互操作性特征外,在管理表型信息的能力方面还观察到了很大的异质性。分析和可视化功能在很大程度上取决于所考虑的平台。同样,系统的可用性是可变的。本文旨在为读者提供选择最适合其需求的平台的背景。总而言之,我们在隐私,互操作性和技术功能方面讨论了最佳翻译研究平台的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号